PARP1 and Parkinson disease: Inhibition of PARP activity or Parp1 gene deletion fully mitigates neuron-to-neuron transmission of pathologic α-synuclein and neurotoxicity; thus, PARP inhibitors (PARPi) can be exploited as therapeutic intervention for PD [110].